Effect of Bone Strontium on BMD Measurements
- 1 January 2007
- journal article
- Published by Elsevier in Journal of Clinical Densitometry
- Vol. 10 (1) , 34-38
- https://doi.org/10.1016/j.jocd.2006.10.004
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Strontium Ranelate Reduces the Risk of Vertebral and Nonvertebral Fractures in Women Eighty Years of Age and OlderJournal of Bone and Mineral Research, 2006
- Vertebral Fracture Risk Reduction With Strontium Ranelate in Women With Postmenopausal Osteoporosis Is Independent of Baseline Risk FactorsJournal of Bone and Mineral Research, 2006
- Strontium Ranelate Reduces the Risk of Nonvertebral Fractures in Postmenopausal Women with Osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) StudyJournal of Clinical Endocrinology & Metabolism, 2005
- The Effects of Strontium Ranelate on the Risk of Vertebral Fracture in Women with Postmenopausal OsteoporosisNew England Journal of Medicine, 2004
- Prevention of Early Postmenopausal Bone Loss by Strontium Ranelate: The Randomized, Two-Year, Double-Masked, Dose-Ranging, Placebo-Controlled PREVOS TrialOsteoporosis International, 2002
- Strontium Ranelate: Dose-Dependent Effects in Established Postmenopausal Vertebral Osteoporosis--A 2-Year Randomized Placebo Controlled TrialJournal of Clinical Endocrinology & Metabolism, 2002
- Effects of Risedronate Treatment on Vertebral and Nonvertebral Fractures in Women With Postmenopausal OsteoporosisA Randomized Controlled TrialJAMA, 1999
- Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With RaloxifeneResults From a 3-Year Randomized Clinical TrialJAMA, 1999
- Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fracturesThe Lancet, 1996
- Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal OsteoporosisNew England Journal of Medicine, 1995